Acadia Healthcare (ACHC)
(Delayed Data from NSDQ)
$73.59 USD
+0.21 (0.29%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $73.64 +0.05 (0.07%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Income Statements
Fiscal Year end for Acadia Healthcare Company, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 2,929 | 2,610 | 2,314 | 2,090 | 3,107 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 2,929 | 2,610 | 2,314 | 2,090 | 3,107 |
Selling & Adminstrative & Depr. & Amort Expenses | 2,416 | 2,143 | 1,900 | 1,724 | 2,703 |
Income After Depreciation & Amortization | 513 | 468 | 414 | 366 | 405 |
Non-Operating Income | -456 | -24 | -62 | -24 | -81 |
Interest Expense | 82 | 70 | 77 | 158 | 187 |
Pretax Income | -25 | 374 | 276 | 184 | 136 |
Income Taxes | -10 | 94 | 68 | 41 | 26 |
Minority Interest | 6 | 7 | 5 | 3 | 1 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -16 | 280 | 208 | 143 | 110 |
Extras & Discontinued Operations | 0 | 0 | -13 | -812 | 0 |
Net Income (GAAP) | -22 | 273 | 191 | -672 | 109 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 649 | 589 | 525 | 473 | 581 |
Depreciation & Amortization (Cash Flow) | 136 | 121 | 111 | 108 | 176 |
Income After Depreciation & Amortization | 513 | 468 | 414 | 366 | 405 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 90.95 | 91.56 | 90.79 | 88.60 | 87.82 |
Diluted EPS Before Non-Recurring Items | 3.44 | 3.01 | 2.56 | 2.78 | 2.04 |
Diluted Net EPS (GAAP) | -0.24 | 2.98 | 2.10 | -7.59 | 1.24 |
Fiscal Year end for Acadia Healthcare Company, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 742.80 | 750.33 | 731.34 | 704.27 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 742.80 | 750.33 | 731.34 | 704.27 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 615.78 | 611.56 | 596.23 | 592.16 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 127.02 | 138.77 | 135.11 | 112.11 |
Non-Operating Income | NA | -36.33 | -405.43 | -17.77 | -6.47 |
Interest Expense | NA | 20.47 | 20.74 | 20.91 | 20.00 |
Pretax Income | NA | 79.97 | -287.40 | 96.43 | 85.64 |
Income Taxes | NA | 20.21 | -71.87 | 22.88 | 19.09 |
Minority Interest | NA | 2.03 | 2.19 | 1.25 | 0.54 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 59.76 | -215.53 | 73.55 | 66.56 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 57.73 | -217.71 | 72.30 | 66.02 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 91.87 | 91.17 | 91.55 | 91.39 |
Diluted EPS Before Non-Recurring Items | NA | 0.85 | 0.91 | 0.92 | 0.75 |
Diluted Net EPS (GAAP) | NA | 0.64 | -2.39 | 0.79 | 0.72 |